<DOC>
	<DOCNO>NCT02155205</DOCNO>
	<brief_summary>The purpose study demonstrate telotristat etiprate differ placebo mean change Baseline QT interval correct heart rate .</brief_summary>
	<brief_title>A Thorough QT Study Telotristat Etiprate</brief_title>
	<detailed_description />
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Healthy adult male female ≥18 ≤55 year age ( inclusive ) time Screening Body mass index ≥18 ≤32 kg/m2 Screening Vital sign ( least 5 minute rest supine position ) Screening within follow range : Systolic blood pressure 90 140 mm Hg , Diastolic blood pressure 50 90 mm Hg , heart rate 45 100 beat per minute ( bpm ) Clinical laboratory evaluation ( include clinical chemistry panel [ fast least 10 hour ] , complete blood count , urinalysis [ UA ] ) within reference range test laboratory , unless deem clinically significant Investigator Able tolerate prolong period quiet , motionless , supervise rest Willing adhere prohibition restriction specify protocol Able comprehend willing sign Informed Consent Form Presence clinically significant physical , laboratory , ECG finding Screening , opinion Investigator Sponsor , may interfere aspect study conduct interpretation result &gt; 30 premature ventricular beat per hour Holter ECG monitoring Day 1 Period 1 ( monitor clinic via telemetry ) History additional risk factor torsade de pointes diagnosis suggestion family history short QT syndrome long QT syndrome History renal disease significantly abnormal kidney function test History hepatic disease significantly abnormal liver function test History clinically significant psychiatric , renal , hepatic , pancreatic , cardiovascular , neurological , gastrointestinal abnormality Concurrent condition could interfere safety tolerability measurement Positive hepatitis panel ( include hepatitis B surface antigen hepatitis C virus antibody ) positive human immunodeficiency virus antibody screen Use tobacco , use medication , history disease condition might interfere conduct study opinion investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>